Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues
International Journal of Molecular Sciences · 15.08.2024 · 25 (16) · 8885
DOI: 10.3390/ijms25168885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.08.2024. Verfasst von Amira Zaher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Hydrogen Peroxide, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Radiation Research Foundation.
Abstract (Originalsprache)
Conventional cancer therapy strategies, although centered around killing tumor cells, often lead to severe side effects on surrounding normal tissues, thus compromising the chronic quality of life in cancer survivors. Hydrogen peroxide (H2O2) is a secondary signaling molecule that has an array of functions in both tumor and normal cells, including the promotion of cell survival pathways and immune cell modulation in the tumor microenvironment. H2O2 is a reactive oxygen species (ROS) crucial in cellular homeostasis and signaling (at concentrations maintained under nM levels), with increased steady-state levels in tumors relative to their normal tissue counterparts. Increased steady-state levels of H2O2 in tumor cells, make them vulnerable to oxidative stress and ultimately, cell death. Recently, H2O2-producing therapies—namely, pharmacological ascorbate and superoxide dismutase mimetics—have emerged as compelling complementary treatment strategies in cancer. Both pharmacological ascorbate and superoxide dismutase mimetics can generate excess H2O2 to overwhelm the impaired H2O2 removal capacity of cancer cells. This review presents an overview of H2O2 metabolism in the physiological and malignant states, in addition to discussing the anti-tumor and normal tissue-sparing mechanism(s) of, and clinical evidence for, two H2O2-based therapies, pharmacological ascorbate and superoxide dismutase mimetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Amira Zaher, Kranti A Mapuskar
Förderung
- NCI NIH HHS
- NIH HHS
- Radiation Research Foundation
- Holden Comprehensive Cancer Center
- Carver College of Medicine
- NIH
Zitieren
APA
Zaher, A., Petronek, M. S., Allen, B. G., & Mapuskar, K. A. (2024). Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues. International Journal of Molecular Sciences, 25(16), 8885. https://doi.org/10.3390/ijms25168885
Vancouver
Zaher A, Petronek MS, Allen BG, Mapuskar KA. Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues. International Journal of Molecular Sciences. 2024;25(16):8885. doi:10.3390/ijms25168885
BibTeX
@article{Zaher2024,
author = {Zaher, Amira and Petronek, Michael S and Allen, Bryan G and Mapuskar, Kranti A},
title = {Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {8885},
doi = {10.3390/ijms25168885}
}
EUVIMED